Link Cell Therapies
Link Cell Therapies develops engineered cell therapy technologies intended to create targeted CAR T-based treatments for cancer. The company applies proprietary logic-gating methods that require co-expression of multiple cancer antigens to activate therapeutic T cells, aiming to focus immune cell activity on tumor cells while reducing effects on non-cancerous tissues. Its work spans programs for solid tumors and certain hematologic cancers, with lead candidates progressing through preclinical development and preparation for clinical research. Link Cell Therapies also explores additional platforms and therapeutic programs that build on its core targeting technology to expand applications of engineered cellular therapies.
Domain
linkcelltx.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$60.0M
Founded
2021
Tech Stack (19 technologies)
Frequently Asked Questions
What technologies does Link Cell Therapies use?+
Link Cell Therapies uses 19 technologies including Google Analytics, Google Tag Manager, Modernizr.
What industry is Link Cell Therapies in?+
Link Cell Therapies operates in the Biotechnology industry.
Where is Link Cell Therapies based?+
Link Cell Therapies is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026